Merck Sharp & Dohme LLC
🏢 View company profile →2,399Patents
1,991Active
2,399Granted
62Portfolio score
Filing activity: Dec 23, 1980 → Sep 19, 2024 · 660 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5514718A | Heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing them | Chemistry; Metallurgy | 531 | Expired |
| US8168757B2 | PD-1 binding proteins | Chemistry; Metallurgy | 319 | Active |
| US8900587B2 | Antibodies to human programmed death receptor PD-1 | Physics | 128 | Active |
| USD780909S1 | Autoinjector pen | General | 100 | Active |
| US7879815B2 | Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection | Human Necessities | 100 | Active |
| US7833992B2 | Conjugates and compositions for cellular delivery | Emerging Cross-Sectional Technologies | 97 | Active |
| US5880132A | Tachykinin antagonist and an opioid analgesic effective at treating pain or nociception | Human Necessities | 93 | Expired |
| US8188234B2 | 1D05 PCSK9 antagonists | Chemistry; Metallurgy | 87 | Active |
| USD774641S1 | Auto injector | General | 84 | Active |
| US8273866B2 | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SINA) | Chemistry; Metallurgy | 81 | Active |
| US8188233B2 | 1B20 PCSK9 antagonists | Chemistry; Metallurgy | 81 | Active |
| US8648185B2 | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) | Emerging Cross-Sectional Technologies | 80 | Active |
| US8618277B2 | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) | Chemistry; Metallurgy | 79 | Active |
| US6172077A | Spiro-azacyclic derivatives and their use as therapeutic agents | Human Necessities | 74 | Expired |
| US6214846A | Substituted 3-(benzylamino)piperidine derivatives and their use as therapeutic agents | Chemistry; Metallurgy | 74 | Expired |
| US8148349B2 | Nucleoside cyclic phosphoramidates for the treatment of RNA-dependent RNA viral infection | Human Necessities | 72 | Active |
| US5298520A | Triazole containing indole derivatives | Chemistry; Metallurgy | 72 | Expired |
| US8071568B2 | Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection | Chemistry; Metallurgy | 71 | Active |
| USD857192S1 | Autoinjector device | General | 70 | Active |
| US6479480B1 | Phenylindole derivatives as 5-ht2a receptor ligands | Chemistry; Metallurgy | 69 | Expired |
| US5106853A | Oxadiazole and its salts, their use in treating dementia | Human Necessities | 67 | Expired |
| US7775056B2 | Intelligent refrigerator for storing pharmaceutical product containers | Mechanical Engineering; Lighting; Heating | 67 | Active |
| US5556969A | Benzodiazepine derivatives | Chemistry; Metallurgy | 63 | Expired |
| US5346906A | Substituted pyridines, their preparation, formulations and use in dementia | Chemistry; Metallurgy | 62 | Expired |
| USD793547S1 | Autoinjector pen | General | 60 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.